acquired
Stage
2002
Founded
1
Investors
About
Intercept Pharmaceuticals develops and commercializes therapeutics focused on treating rare and serious liver diseases using proprietary bile acid chemistry and FXR biology.
Explore Intercept Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.